Autonomix Medical
Trent Smith is the Chief Financial Officer at Autonomix Medical, Inc. Known for their extensive experience in financial management, audit, and reporting, Trent has held various leadership positions in companies such as Soliton, Inc., InfuSystem, Inc., and SYNCREON. Trent played a crucial role in preventing bankruptcy at one company and establishing SEC reporting procedures at another. With a Bachelor's degree in Accounting from the University of Illinois Urbana-Champaign, Trent has a strong foundation in finance and accounting.
This person is not in any teams
Autonomix Medical
Autonomix (Nasdaq: AMIX) is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. We are initially developing our technology for pancreatic cancer pain, a condition that can cause debilitating pain and needs an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum.